Drug factory · FDA FEI 3008580332
Eurofins Infinity Laboratory Group Inc.
2200 W 97th Place, Crown Point, IN, United States
No problems found at FDA's last inspection, Mar 5, 2026.
No Action Indicated: inspectors found no objectionable conditions.
3 drug inspections on record since 2014: 3 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Buprenorphine and Naloxone | Tests it | Indivior Inc. | 12496-1202, 12496-1204, 12496-1208 +1 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 5, 2026 | No problems found | Drug Quality Assurance | — |
| Nov 27, 2018 | No problems found | Drug Quality Assurance | — |
| Apr 4, 2014 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis.